Current glycaemic control has no impact on the advancement of diabetic neuropathy

被引:0
|
作者
Dziemidok, Piotr [1 ,2 ]
Szczesniak, Grzegorz [1 ]
Kostrzewa-Zablocka, Ewa [1 ]
Paprzycki, Piotr [3 ]
Korzon-Burakowska, Anna [4 ]
机构
[1] Inst Rural Hlth, Diabetol Ward, PL-20090 Lublin, Poland
[2] Pope John Paul II State Sch Higher Educ, Inst Publ Hlth, Biala Podlaska, Poland
[3] Inst Rural Hlth, Dept Funct Res, PL-20090 Lublin, Poland
[4] Med Univ, Dept Hypertens & Diabetol, Gdansk, Poland
关键词
diabetic neuropathy; glycemic control; glycated haemoglobin; diabetes complications; long term diabetes; ALPHA-LIPOIC ACID; PERIPHERAL NEUROPATHY; SENSORY SYMPTOMS; COMPLICATIONS; POPULATION; PREVALENCE; COMMUNITY; COHORT;
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The aim of the study was to assess the association between glycemic control understanding as a glycated haemoglobin level and indices of diabetic neuropathy. Methods: We evaluated 204 patients with diabetes (type 1 - 29; type 2 - 175). Glycated haemoglobin was determined using The Diabetes Control and Complications Trial/National Glycohemoglobin Standardization Program method. Evaluation of complaints from the lower extremities was based on the Neuropathy Syndrome Total Score questionnaire. We used a monofilament for evaluation of touch sensation (Semmes-Weinstein 5.07-10 g), a 128 Hz calibrated tune-fork for the vibration perception test, Tip-Therm to assess temperature sensation. Results: The mean glycated haemoglobin level was assessed on 8.53+/-1.87%. The mean Neuropathy Syndrome Total Score: 11.45+/-6.37. Decreased sensation of touch on both sides was determined in 30% of cases, decreased sensation of temperature in 59% and decreased sensation of vibration in 30%. For Neuropathy Syndrome Total Score and glycated haemoglobin the Pearson's correlation test was 0.00910 (p approximate to 0.99), Spearman's rank correlation test was 0.00523 (p approximate to 0.95). Persons with sensation deficits and neuropathy symptoms had not significantly higher (Neuropathy Syndrome Total Score, temperature sensation disturbances) and not significantly lower (vibration and touch) glycated haemoglobin level compared to patients without neuropathy. Conclusion: There is no correlation between prevalence and advancement of sensorial neuropathy and current diabetes control in patients with long-term established diabetes.
引用
收藏
页码:742 / 745
页数:4
相关论文
共 50 条
  • [1] Is the advancement of diabetic angiopathy evaluated as ankle-brachial index directly associated with current glycaemic control?
    Dziemidok, Piotr
    Szczesniak, Grzegorz
    Kostrzewa-Zablocka, Ewa
    Paprzycki, Piotr
    Korzon-Burakowska, Anna
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2012, 19 (03) : 563 - 566
  • [2] Current advancement in the preclinical models used for the assessment of diabetic neuropathy
    Saini, Tanishk
    Mazumder, Papiya Mitra
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 2727 - 2745
  • [3] Current advancement in the preclinical models used for the assessment of diabetic neuropathy
    Tanishk Saini
    Papiya Mitra Mazumder
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2024, 397 : 2727 - 2745
  • [4] The impact of demographic and clinical characteristics on diabetic painful neuropathy
    Assuncao, Antonio
    Campos, Dina
    Marques, Rui
    Cunha, Ines
    Santos, Patricia
    Martins, Adriana
    Goncalves, Ana Sofia
    Rebelo, Ana
    Lima, Carolina
    Matos, Cesar
    Prata, Ana Cristina
    Teixeira, Jose Tiago
    Duarte, Luis
    Belo, Mariana
    Figueiredo, Patricia
    Rosa, Tiago Letras
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2020, 58 (01) : 13 - 19
  • [5] Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review)
    Bondar, Andrei
    Popa, Amorin Remus
    Papanas, Nikolaos
    Popoviciu, Mihaela
    Vesa, Cosmin Mihai
    Sabau, Monica
    Daina, Cristian
    Stoica, Roxana Adriana
    Katsiki, Niki
    Stoian, Anca Pantea
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [6] Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control
    Sorensen, L
    Molyneaux, L
    Yue, DK
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (01) : 45 - 51
  • [7] Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: The EURODIAB IDDM Complications Study
    Tesfaye, S
    Stevens, LK
    Stephenson, JM
    Fuller, JH
    Plater, M
    IonescuTirgoviste, C
    Nuber, A
    Pozza, G
    Ward, JD
    DIABETOLOGIA, 1996, 39 (11) : 1377 - 1384
  • [8] Understanding the impact of painful diabetic neuropathy
    Quattrini, C
    Tesfaye, S
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2003, 19 : S2 - S8
  • [9] Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice
    Ziegler, Dan
    Schneider, Edith
    Boess, Frank G.
    Berggren, Lovisa
    Birklein, Frank
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2014, 28 (05) : 698 - 704
  • [10] Current Strategies for the Management of Painful Diabetic Neuropathy
    Staudt, Michael D.
    Prabhala, Tarun
    Sheldon, Breanna L.
    Quaranta, Nicholas
    Zakher, Michael
    Bhullar, Ravneet
    Pilitsis, Julie G.
    Argoff, Charles E.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (02): : 341 - 352